Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma

BACKGROUND: Ramucirumab (RAM), a monoclonal antibody for vascular endothelial growth factor 2 (VEGFR2), has been effective for advanced gastric adenocarcinoma (AC). However, little is known about the efficacy of RAM-containing chemotherapy (RAM-CTx) in gastric neuroendocrine carcinoma (G-NEC). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Saori, Kawazoe, Akihito, Matsumoto, Hiroshi, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Doi, Toshihiko, Ohtsu, Atsushi, Yoshino, Takayuki, Nonte, Elizabeth M, Chintharlapalli, Sudhakar, Nasir, Aejaz, Kuwata, Takeshi, Shitara, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212678/
https://www.ncbi.nlm.nih.gov/pubmed/30425849
http://dx.doi.org/10.1136/esmoopen-2018-000443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212678/
https://www.ncbi.nlm.nih.gov/pubmed/30425849
http://dx.doi.org/10.1136/esmoopen-2018-000443

Ejemplares similares